By proceeding, you agree to our Terms of Use and Privacy Policy.
Boro Dropulić has worked in the gene therapy field since the late 1980s. After four years in academic research in the US, he founded his first company, ViRxSys, and led the team that first demonstrated the safety of lentiviral vectors in humans.
Talks About #biotechnology #cell
Preferred Locations #Northamerica